Nebratamig
Nebratamig (GNC-035) is an anti-ROR1/anti-CD3/anti-PD-L1/anti-4-1BB tetra-specific antibody with potential immunostimulatory and antineoplastic activities[1].
Product Specifications
CAS Number
2694723-68-5
Product Name Alternative
GNC-035
UNSPSC
12352203
Target
CD3; PD-1/PD-L1; ROR
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Purity
97.34
Smiles
[Nebratamig]
Molecular Weight
(302.32 kDa)
References & Citations
[1]https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nebratamig
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471594-100 1x 100 µL
CD22 / BL-CAM (B-Cell Marker) (RFB4), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880296-100 1x 100 µL
Blood Group Antigen B (CD173) (HEB-20), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details